-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Chemours, Lowers Price Target to $13

Benzinga·12/03/2025 16:04:25
语音播报
JP Morgan analyst Jeffrey Zekauskas maintains Chemours (NYSE:CC) with a Neutral and lowers the price target from $15 to $13.